Item 9 Labs Stock Performance
| INLB Stock | USD 0.0001 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Item 9 are completely uncorrelated.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Item 9 Labs are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile essential indicators, Item 9 sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.5 M |
Item |
Item 9 Relative Risk vs. Return Landscape
If you would invest 0.01 in Item 9 Labs on December 14, 2024 and sell it today you would earn a total of 0.00 from holding Item 9 Labs or generate 0.0% return on investment over 90 days. Item 9 Labs is currently generating 15.0% in daily expected returns and assumes 129.9609% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Item, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Item 9 Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Item 9's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Item 9 Labs, and traders can use it to determine the average amount a Item 9's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1154
| Best Portfolio | Best Equity | INLB | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 129.96 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Item 9 is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Item 9 by adding it to a well-diversified portfolio.
Item 9 Fundamentals Growth
Item Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Item 9, and Item 9 fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Item Pink Sheet performance.
| Return On Equity | -0.42 | |||
| Return On Asset | -0.0721 | |||
| Profit Margin | (1.43) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 52.06 M | |||
| Shares Outstanding | 100 M | |||
| Price To Book | 0.28 X | |||
| Price To Sales | 0.95 X | |||
| Revenue | 21.76 M | |||
| EBITDA | (22.83 M) | |||
| Cash And Equivalents | 441.66 K | |||
| Total Debt | 7.22 M | |||
| Debt To Equity | 0.39 % | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (2.25 M) | |||
| Earnings Per Share | (0.18) X | |||
| Total Asset | 110.76 M | |||
About Item 9 Performance
By analyzing Item 9's fundamental ratios, stakeholders can gain valuable insights into Item 9's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Item 9 has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Item 9 has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.Things to note about Item 9 Labs performance evaluation
Checking the ongoing alerts about Item 9 for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Item 9 Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Item 9 Labs is way too risky over 90 days horizon | |
| Item 9 Labs has some characteristics of a very speculative penny stock | |
| Item 9 Labs appears to be risky and price may revert if volatility continues | |
| Item 9 Labs has high likelihood to experience some financial distress in the next 2 years | |
| Item 9 Labs currently holds 7.22 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Item 9 Labs has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Item 9 until it has trouble settling it off, either with new capital or with free cash flow. So, Item 9's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Item 9 Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Item to invest in growth at high rates of return. When we think about Item 9's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 21.76 M. Net Loss for the year was (31.14 M) with profit before overhead, payroll, taxes, and interest of 7.31 M. | |
| Item 9 Labs currently holds about 441.66 K in cash with (2.25 M) of positive cash flow from operations. | |
| Roughly 26.0% of Item 9 shares are held by company insiders |
- Analyzing Item 9's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Item 9's stock is overvalued or undervalued compared to its peers.
- Examining Item 9's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Item 9's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Item 9's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Item 9's pink sheet. These opinions can provide insight into Item 9's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Item Pink Sheet analysis
When running Item 9's price analysis, check to measure Item 9's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Item 9 is operating at the current time. Most of Item 9's value examination focuses on studying past and present price action to predict the probability of Item 9's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Item 9's price. Additionally, you may evaluate how the addition of Item 9 to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |